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ABSTRACT
Objectives To examine the clinical and cost-
effectiveness of brief advice for excessive alcohol
consumption among people who attend sexual health
clinics.
Methods Two-arm, parallel group, assessor blind,
pragmatic, randomised controlled trial. 802 people aged
19 years or over who attended one of three sexual
health clinics and were drinking excessively were
randomised to either brief advice or control treatment.
Brief advice consisted of feedback on alcohol and health,
written information and an offer of an appointment with
an Alcohol Health Worker. Control participants received
a leaﬂet on health and lifestyle. The primary outcome
was mean weekly alcohol consumption during the
previous 90 days measured 6 months after
randomisation. The main secondary outcome was
unprotected sex during this period.
Results Among the 402 randomised to brief advice,
397 (99%) received it. The adjusted mean difference in
alcohol consumption at 6 months was −2.33 units per
week (95% CI −4.69 to 0.03, p=0.053) among those
in the active compared to the control arm of the trial.
Unprotected sex was reported by 154 (53%) of those
who received brief advice, and 178 (59%) controls
(adjusted OR=0.89, 95% CI 0.63 to 1.25, p=0.496).
There were no signiﬁcant differences in costs between
study groups at 6 months.
Conclusions Introduction of universal screening and
brief advice for excessive alcohol use among people
attending sexual health clinics does not result in
clinically important reductions in alcohol consumption or
provide a cost-effective use of resources.
Trial registration number Current Controlled Trials
ISRCTN 99963322.
INTRODUCTION
Concerns have been raised about high levels of
alcohol consumption among people attending
sexual health clinics.1 Cross-sectional surveys have
repeatedly demonstrated that many people attend-
ing sexual health clinics drink above recommended
levels.2 3 In a consecutive sample of over 500
people attending a sexual health clinic in the south
of England, Standerwick and colleagues found that
86% were drinking above recommended limits,
and that those drinking excessively were more
likely to be diagnosed with a sexually transmitted
infection.4 Brief advice for excessive alcohol con-
sumption has been shown to be effective across a
range of medical settings, and to reduce the likeli-
hood of accidents and injuries,5 6 but there is little
evidence about its impact when offered to people
attending sexual health clinics. The only clinical
trial, to date, was conducted by Lane and collea-
gues in Sydney, Australia.7 One hundred and
eighty-four people who attended a sexual health
clinic and were found to be drinking excessively
were randomised to a brief alcohol intervention
lasting 5–10 min or to control treatment. Those
allocated to the active arm of the trial were more
likely to state that they were drinking less 3 months
later, but differences in the total score on the
Alcohol Use Disorders Identiﬁcation Test were not
found.
The SHEAR (Sexual Health and Excessive
Alcohol: Randomised trial) study was set up to
examine the clinical and cost-effectiveness of
opportunistic brief advice for excessive alcohol use
among people who attend sexual health clinics. To
achieve this aim we examined whether brief advice
reduced subsequent alcohol consumption and
altered sexual behaviour 6 months later compared
with control treatment, and whether it provided a
cost-effective use of resources.
METHODS
The trial was a two-arm, parallel group, assessor-
blind, randomised controlled trial. Ethical approval
was obtained from West London Research Ethics
Committee 3 (10/H0706/29), and the study proto-
col was registered with Controlled Clinical Trials
(ISRCTN 99963322) prior to data collection. The
detailed study protocol has been published else-
where,8 and key features are described here.
Study participants were recruited in three sexual
health clinics in central and west London. To take
part in the study, potential participants had to be
aged 19 years or above, be drinking excessively
according to the Modiﬁed-Single Alcohol Screening
Question (M-SASQ),9 and be willing to provide
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written informed consent. According to the M-SASQ, men who
drink more than eight standard drinks on one occasion once a
month or more, and women who drink more than six standard
drinks on one occasion once a month or more are considered to
be drinking excessively. We excluded any person who was
unable to communicate in English sufﬁciently to complete base-
line questionnaires, anyone who did not have an address or
contact telephone number, and anyone who believed they may
not be contactable again 6 months later.
Study procedures
Clinic staff gave all those attending the service a postcard with
information about the study. Those who agreed to meet a
researcher were given information about the study and asked to
provide written informed consent. Following assessment of eligi-
bility, baseline data were collected using a computer-assisted self-
completion questionnaire. Participants were then randomised
via a remote telephone service provided by an independent
Clinical Trials Unit using permuted blocks, stratiﬁed by site.
Block size was randomly assigned between four and six, with an
equal allocation probability between arms. Researchers who col-
lected follow-up data at 6 months were blinded to allocation
status. Participants who completed the follow-up interview were
offered a £15 honorarium in recognition of their time and any
inconvenience related to their involvement in the study.
Interventions
The SHEAR study had two treatment conditions. Those rando-
mised to control treatment received a general health information
leaﬂet with advice about smoking, alcohol, diet and exercise. In
the brief advice group, participants were given feedback from
the treating clinician (lasting 2–3 min) which consisted of infor-
mation about the possible health consequences of excessive
alcohol consumption, written information about alcohol and
health and an offer of an appointment with an Alcohol Health
Worker (AHW). Brief intervention with the AHW lasted up to
30 min and used the ‘FRAMES’ approach which combines
active listening and feedback about risks associated with exces-
sive alcohol consumption and emphasises personal responsibility
for change.10 11 For any participant who was drinking at a
harmful or dependent level, the AHW had the option of arran-
ging a follow-up appointment or referring them on to local
alcohol services for individual alcohol counselling, detoxiﬁca-
tion, or other treatments. If the participant was unable to attend
an appointment on the day they were seen, then the AHW
offered them an appointment at a later date or the option of
telephone-based information and advice.
All clinicians who treated study patients received training on
delivering brief advice prior to the start of the study. In addition
to this, the lead researcher RS spoke to front-line clinicians on
the days when recruitment was taking place. She provided
support and advice to clinicians, gave feedback on their per-
formance, and checked that brief advice was being delivered in
accordance with the trial protocol. All AHWs who took part in
the study were experienced practitioners who had undertaken
speciﬁc training in counselling people who misuse alcohol. They
each received regular clinical supervision during the trial and
were encouraged to discuss work with trial participants along
with other patients they saw during these sessions.
Clinicians delivering brief advice and AHWs were asked to
complete a treatment proforma for each person they saw. These
proforma were based on ones we used in a previous trial,12 and
required clinicians to indicate whether they had delivered each
of the four components of brief advice and AHWs to record the
number and length of session(s), interventions delivered during
the session(s) and further information of referrals that were sub-
sequently made. Proforma were examined at the end of the
study to examine treatment ﬁdelity.
Outcome measures
All outcomes were measured 6 months after randomisation and
assessed behaviour in the 3 months prior to the date of the
assessment. The primary outcome was mean weekly alcohol
consumption (measured using the Form 90),13 and the main sec-
ondary outcome was the proportion of participants who
reported any unprotected sex during the previous 3 months.
Other secondary outcomes included mean units of alcohol con-
sumed per drinking day, percentage days abstinent (both mea-
sured using the Form 90), and whether the participant was
drinking excessively (deﬁned as more than eight UK units/64 g
of alcohol on one occasion for men, and more than six UK
units/48 g for women).9 Sexual behaviour outcomes included
total number of sexual partners, number of unprotected sexual
partners, any incidence of regretted sex, any incidence of unpro-
tected sex after drinking alcohol or while drunk, how long they
knew their last sexual partner before they had sex with them,
unplanned pregnancy and any new diagnosis of a sexually trans-
mitted infection. These were assessed using questions derived
from a previous study.14 Finally, we collected data on
health-related quality of life (measured using the EuroQol-5
Dimensions scale; EQ-5D),15 and health and social care
resource use during the past 6 months measured using a modi-
ﬁed version of the Adult Service Use Schedule (AD-SUS).16 The
cost of the brief advice was directly calculated from salaries
using a microcosting approach, and national UK unit costs for
the year 2010–2011 were applied to medication, hospital con-
tacts and community health and social services.17 18
Statistical methods
The initial sample size calculation was based on identifying dif-
ferences in mean weekly alcohol consumption as found in our
previous trial of brief advice in an emergency department12 and
suggested a minimum of 160 per arm.8 However, in the ﬁrst
few months of the trial the rate of recruitment was higher than
expected and the sample size was therefore increased to provide
additional power to test the primary and main secondary out-
comes. The ﬁnal sample size was based on a practical size of
380 per arm (760 in total). If the intervention reduced the pro-
portion of participants who had unprotected sex from 65% to
50%, the power to detect a signiﬁcant difference would be
above 90%, assuming 25% drop out, and a clustering design
effect of 1.15.
The statistical methods and trial design were speciﬁed a priori
in a protocol paper8 and in a further detailed Statistical Analysis
Plan.19 All analysis was performed in STATA (V.12). The
primary outcome, mean weekly alcohol consumption, was com-
pared between the randomised groups using random-effects
linear regression, adjusted for age, sex and harmful alcohol use
at baseline. The random-effects model takes into account clus-
tering by sexual health clinic and, in the intervention arm, by
treating clinician.20 Despite the skewed distribution of the
outcome data, we used ordinary parametric models, which
enables inference to be made about the arithmetic mean and are
sufﬁciently robust to skewed outcome in a large sample.21
Robustness of the result was assessed by various sensitivity
analyses, including non-parametric bootstrapping and non-
hierarchical linear models. The main secondary outcome, pro-
portion of participants reporting any unprotected sex, was
Health services research
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analysed using random-effects logistic regression, adjusted for
age, gender, and unprotected sex in the previous 6 months at
baseline. Other secondary outcomes were analysed by linear,
logistic or negative binomial regression. For rare outcomes,
exact tests were used, and CIs calculated using mid-p method.22
All analyses were carried out according to the allocated random-
isation arm, and two-sided p values were considered signiﬁcant
when below 0.05.
Patients with missing data were excluded in primary ‘com-
plete case’ analyses, with multiple imputation using chained
equations performed as a sensitivity analysis.23 Outcomes, cov-
ariates, predictors of outcomes and predictors of missingness
were included in the imputation model, with both arms
imputed separately in order to allow for interactions. A range of
Missing Not at Random mechanisms were then considered in
further sensitivity analyses to assess the robustness of the
primary results.24
The economic evaluation took a NHS/Personal Social Service
perspective and had a 6-month time horizon. Standard paramet-
ric tests were used for the analysis of cost data, as recom-
mended,21 with the robustness of the test conﬁrmed using
non-parametric bootstrapping.25 Effectiveness was assessed in
terms of health-related Quality Adjusted Life Years (QALY)
derived from the EQ-5D.26 The cost-effectiveness of the brief
advice was assessed through the generation of cost-effectiveness
acceptability curves (CEACs), which present the probability that
the advice is cost-effective for different values a decision maker
might be willing to pay for an improvement in outcome.27
RESULTS
Of 1649 people who were assessed for the study between
August 2010 and May 2012, 802 (49%) met our inclusion cri-
teria. Recruitment stopped at this point as the revised target
sample size had been exceeded and a decision was made to stop
recruitment in a trial management meeting. Of those rando-
mised, 592 (74%) were followed-up at 6 months. Reasons for
non-participation and attrition are presented in ﬁgure 1, and
baseline characteristics of participants are presented in table 1.
Participants had a median age of 27 years (IQR=24 to 30), and
432 (54%) were female. All but ﬁve (1.2%) of the 402 partici-
pants who were randomised to the active arm of the trial
received brief advice from the treating clinician. Among 370 in
the active arm of the trial who were asked whether there was a
link between their alcohol use and their attendance at the clinic,
70 (19%) said there was.
Data from treatment proforma showed that, of the 402 ran-
domised to brief intervention, 397 (99%) received brief feed-
back that alcohol use at that level has the potential to harm
health, 370 (92%) were asked whether there was a link between
alcohol use and attendance at the clinic, 397 (99%) were given
a leaﬂet on alcohol and health, of whom 372 (92.5%) took the
leaﬂet, and 397 (99%) were offered an appointment with an
AHW.
Of the 397 offered an appointment with an AHW, 81 (20%)
received input either by phone (N=48) or in a face-to-face
meeting (N=33). Follow-up researchers reported nine occasions
when they became aware of a participants’ allocation status, all
were from the intervention arm.
Primary and secondary outcomes at the 6 month follow-up
are described in table 2. At 6 month follow-up, participants in
the active treatment arm of the trial were drinking a mean of
18.1 units per week compared to 20.3 units among controls;
adjusted mean difference in alcohol consumption=−2.33 units
per week (95% CI −4.69 to 0.03, p=0.053). Unprotected sex
was reported by 154 (53%) of those randomised to brief advice
and by 178 (59%) of controls (adjusted OR=0.89, 95% CI
Figure 1 Study ﬂow-chart.
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0.63 to 1.25, p=0.496). Sensitivity analyses regarding statistical
model used and missing data, gave similar ﬁndings of a small
difference around statistical signiﬁcance for the primary
outcome.
The active intervention cost £12.57 on average (SD 6.59)
which was a relatively small addition to total costs (mean
6-month costs £319) (table 3). The control group cost £8 less
on average (mean 6-month cost £311). There were no signiﬁ-
cant differences in costs (8.41; 95% CI −98.56 to 115.37,
p=0.879) or QALYs, which were 0.007 lower in among those
allocated to brief advice (95% CI −0.017 to 0.003, p=0.190).
The cost-effectiveness acceptability curve (see ﬁgure S2—web
only) demonstrates that there is no evidence that brief advice is
cost-effective at any willingness to pay values for a QALY.
DISCUSSION
Data from this randomised trial of brief advice for excessive
alcohol use among people attending sexual health clinics sug-
gests that there is little, if any, difference in alcohol consumption
between those who are and are not offered this advice. At
6 months, people randomly allocated to receive brief advice
were consuming a mean of 2.3 units (18.4 g) of alcohol less per
week than those randomised to the control group. In keeping
with recommendations for interpreting the results of borderline
statistically signiﬁcant results28 we base this conclusion on the
clinical signiﬁcance of the changes we found rather than on the
probability of the difference being the result of chance. While a
statistically signiﬁcant difference in number of units of alcohol
per drinking day was observed, the scale of the difference
(1.1 units/8.8 g), is unlikely to be clinically important.
Signiﬁcant differences in sexual health outcomes were not
found between the groups, though we cannot rule out the possi-
bility that brief advice could be associated with small but clinic-
ally important changes in sexual health outcomes. At under £13
per participant, brief advice was inexpensive. However, when
other costs and QALY outcomes were taken into account we
found that that brief advice is very unlikely to provide a cost-
effective use of resources.
Strengths and weaknesses
The study was sufﬁciently powered to examine clinically import-
ant differences in the primary outcome. We tested an
Table 1 Sociodemographic and clinical characteristics of study participants at baseline
Variable
Control
N=400
Brief advice
N=402
Total
N=802
Clinic (%)
Hospital Site 1 247 (61.8) 248 (61.7) 495 (61.7)
Hospital Site 2 103 (25.8) 103 (25.6) 206 (25.7)
Hospital Site 3 50 (12.5) 51 (12.7) 101 (12.6)
Gender (%)
Male 183 (45.8) 187 (46.5) 370 (46.1)
Female 217 (54.3) 215 (53.5) 432 (53.9)
Age (median, IQR) (N=801) 26.8 (23.4–30.4) 26.3 (23.7–30.4) 26.7 (23.6–30.4)
Ethnicity (N=799) (%)
White 309 (77.6) 309 (77.1) 618 (77.3)
Black/ Mixed 52 (13.1) 52 (13.0) 104 (13.0)
Asian/ Mixed 13 (3.3) 16 (4.0) 29 (3.6)
Other 24 (6.0) 24 (6.0) 48 (6.0)
Sexual orientation (N=801) (%)
Heterosexual 361 (90.5) 325 (80.8) 686 (85.6)
Homosexual 34 (8.5) 59 (14.7) 93 (11.6)
Bisexual 4 (1.0) 18 (4.5) 22 (2.7)
Smoking status (N=801) (%)
No 228 (57.1) 228 (56.7) 456 (56.9)
Yes 171 (42.9) 174 (43.3) 345 (43.1)
Reason for presentation (N=788) (%)
Sexual health check only 166 (42.3) 175 (44.2) 341 (43.3)
Symptoms 188 (48.0) 185 (46.7) 373 (47.3)
Emergency Contraception 6 (1.5) 8 (2.0) 14 (1.8)
Further Treatment/ Vaccination 20 (5.1) 17 (4.3) 37 (4.7)
Other 12 (3.1) 11 (2.8) 23 (2.9)
Drinking 6+/8+ units in one session (N=801) (%)
Monthly 141 (35.3) 153 (38.1) 294 (36.7)
Weekly 253 (63.4) 242 (60.2) 495 (61.8)
Daily 5 (1.3) 7 (1.7) 12 (1.5)
Had unprotected sex in the last six months (N=801) (%)
No 45 (11.3) 78 (19.4) 123 (15.4)
Yes 354 (88.7) 324 (80.6) 678 (84.6)
Number of unprotected sexual partners in the last six months (N=801) Mean 1.7 (SD 1.6) Mean 1.4 (SD 1.3) Mean 1.6 (SD 1.4)
Health related quality of life (EQ-5D) (N=801) 0.892 (SD 0.170) 0.893 (SD 0.166) 0.892 (SD 0.168)
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intervention that was delivered by front-line clinicians and could
be rolled out to other clinics. Limitations of the study were that
all recruitment took place in sexual health clinics in London
and, through limiting exposure of control participants to ques-
tions on alcohol, we had only a small amount of information
about alcohol consumption at baseline. However, the little
Table 2 Outcomes at six month follow-up by trial arm
Outcome over the last three months
Control
N=301
Brief advice
N=291
Coefficient/OR*
95% CI
Weekly alcohol consumption (units)
Mean (SD) 20.3 (16.6) 18.1 (15.6) −2.33
Median (IQR) 15.7 (8.3–29.9) 14.1 (6.5–25.1) −4.69 to 0.03
Had unprotected sex (%)
No 123 (40.9) 137 (47.1) 0.89
Yes 178 (59.1) 154 (52.9) 0.63 to 1.25
Average units on drinking days
Mean (SD) 10.4 (5.8) 9.3 (5.3) −1.13
Median (IQR) 9.4 (6.5–13.4) 8.6 (5.6–11.4) −1.96 to −0.29
Proportion of days abstinent
Mean, (SD) 70.7 (22.6) 70.9 (22.1) 0.20
Median (IQR) 75.6 (62.2–87.8) 75.6 (58.9–87.8) −3.03 to 3.44
Drinking excessively (M-SASQ) (%)
No 55 (18.3) 70 (24.1) 0.70
Yes 246 (81.7) 221 (75.9) 0.46 to 1.05
Number of sexual partners
Mean (SD) 1.9 (2.9) 1.6 (2.2) −0.13
Median (IQR) 1 (1–2) 1 (1–2) −0.29 to 0.02
Number of unprotected partners
Mean (SD) 0.8 (1.1) 0.6 (0.8) −0.11
Median (IQR) 1 (0–1) 1 (0–1) −0.31 to 0.08
Occurrence of regretted sex (%)
No 273 (90.7) 263 (90.4) 1.05
Yes 28 (9.3) 28 (9.6) 0.60 to 1.84
Unprotected sex after drinking (%)
No 165 (54.8) 183 (62.9) 0.79
Yes 136 (45.2) 108 (37.1) 0.56 to 1.11
Unprotected sex after feeling drunk (%)
No 245 (81.4) 234 (80.4) 1.15
Yes 56 (18.6) 57 (19.6) 0.76 to 1.75
Unplanned pregnancy (n=316)
No 160 (98.8) 152 (98.7) 1.05
Yes 2 (1.2) 2 (1.3) 0.16 to 6.79
New diagnosis of sexually transmitted infection
No 287 (95.3) 283 (97.3) 0.58
Yes 14 (4.7) 8 (2.7) 0.25 to 1.384
Health related quality of life (SD) 0.922 (0.144) 0.910 (0.150) −0.013
−0.037 to 0.109
*Coefficient/OR from linear, logistic or negative binomial (number of sexual partners) regression for difference between arms, adjusted for age, gender, clinic and corresponding variable
at baseline. Except for unplanned pregnancy and STI diagnosis where OR are unadjusted, CI mid-p estimates, and p value from Fisher’s exact tests. M-SASQ, Modified-Single Alcohol
Screening Question .
Table 3 Mean cost (£) and Quality Adjusted Life Years (QALYs) per participant over 6-month follow-up
Control
n=301
Brief advice
n=291
Difference 95% CIMean (SD) Mean (SD)
Brief alcohol advice 0 (0) 12.57 (6.59)
Outpatient appointments in sexual health clinic 23.97 (55.16) 25.55 (51.75)
All other hospital services 152.35 (446.7) 133.13 (359.05)
Community health and social services 74.59 (256.89) 60.73 (165.01)
Medication 59.96 (235.87) 87.3 (404.71)
Total cost 310.87 (681.12) 319.28 (662.69) 8.41 −98 to 115.37
QALY 0.457 (0.063) 0.450 (0.066) −0.007 −0.0174 to 0.003
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information we did collect suggests that the groups were well
balanced. We were unable to collect follow-up data from a
quarter of the study sample. Excluding these participants from
the main analysis could have biased the intervention
effect estimate. However, sensitivity analyses demonstrated that
this was unlikely to signiﬁcantly affect the conclusions of the
trial.
Comparison with other studies
The only previous trial of an intervention for excessive
alcohol use among people attending sexual health clinics
reported that people offered active intervention believed they
were drinking less 3 months later.7 However, mean scores on
the primary outcome measure, Alcohol Use Disorders
Identiﬁcation Test, were very similar (11.5 in controls and
10.7 among those offered brief intervention). This study was
not large enough to detect clinically important differences in
alcohol consumption between study groups. The results of
the SHEAR study provide stronger evidence that interven-
tions aimed at reducing alcohol consumption among people
attending sexual health clinics may have very limited, if any,
impact.
This study conﬁrmed high levels of excessive alcohol con-
sumption among people attending sexual health clinics.
While most people were drinking above recommended limits
median weekly alcohol consumption was lower than reported
in previous studies.5 12 There is some evidence that brief
advice is less effective among people who have lower levels
of alcohol consumption,5 and this may be one of the reasons
we did not ﬁnd clinically important differences in alcohol
consumption between those who did and did not receive
brief advice.
It is of note that far fewer participants in this study said that
they thought there was a link between their alcohol consump-
tion and the reason for their presentation to the sexual health
clinic than has been reported in studies in emergency depart-
ments (19% in this study compared to 51% in the latter).29
While people attending sexual health clinics may want to
achieve better sexual health, attempts to reduce alcohol con-
sumption may not be seen by them as a necessary means of
trying to achieve this aim.
A number of clinical trials of brief intervention have been
conducted in different outpatient clinics.30 While patients
treated in specialist oral and maxillofacial clinics may beneﬁt
from brief intervention for excessive alcohol use, those treated
in general medical clinics may not. The ﬁndings of the SHEAR
trial are in keeping with those from studies conducted in
general medical clinics, and challenge current national guide-
lines in England and Wales that healthcare professionals should
routinely carry out alcohol screening when promoting sexual
health.31
CONCLUSIONS
The approach we used in this trial to screen and deliver brief
advice for excessive alcohol consumption among people attend-
ing sexual health clinics did not result in clinically important
reductions in alcohol consumption or provide a cost-effective
use of resources. Alternative approaches to supporting people
who drink excessive alcohol should be developed, tested and
found to be effective before they are introduced into sexual
health clinics.
Key messages
▸ Most people attending sexual health clinics drink alcohol
above recommended levels. Those who do so are more likely
to be diagnosed with sexually transmitted infections.
▸ Brief advice for excessive alcohol consumption is effective in
a range of medical settings, but its impact in sexual health
clinics is not known.
▸ Most people who attend sexual health clinics and drink
excessively are willing to accept brief advice, but few take
up the offer of additional interventions.
▸ Brief alcohol advice, as delivered in this trial, did not lead to
clinically signiﬁcant reductions in alcohol use or changes in
sexual behaviour.
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